Susan A. Jarmin

Egham, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Dose-Dependent Microdystrophin Expression Enhancement in Cardiac Muscle by a Cardiac-Specific Regulatory Element.

Dose-Dependent Microdystrophin Expression Enhancement in Cardiac Muscle by a Cardiac-Specific Regulatory Element.

Journal: Human gene therapy

Published: March 26, 2021

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.

Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.

Journal: Journal of cachexia, sarcopenia and muscle

Published: June 28, 2019

Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.

Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.

Journal: Human molecular genetics

Published: November 05, 2018

PABPN1 gene therapy for oculopharyngeal muscular dystrophy.

PABPN1 gene therapy for oculopharyngeal muscular dystrophy.

Journal: Nature communications

Published: July 08, 2016

Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.

Antisense pre-treatment increases gene therapy efficacy in dystrophic muscles.

Journal: Human molecular genetics

Published: March 30, 2016

Next-generation muscle-directed gene therapy by in silico vector design.

Next-generation muscle-directed gene therapy by in silico vector design.

Journal: Nature communications

Published: November 15, 2015

Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.

Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing.

Journal: Nucleic acids research

Published: November 02, 2015

piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.

piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts.

Journal: Nucleic acids research

Published: August 13, 2015

Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.

Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 23, 2015

Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD).

Adeno-Associated Virus (AAV) Mediated Dystrophin Gene Transfer Studies and Exon Skipping Strategies for Duchenne Muscular Dystrophy (DMD).

Journal: Current gene therapy

Published: December 23, 2014

Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal.

Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 30, 2014

New developments in the use of gene therapy to treat Duchenne muscular dystrophy.

New developments in the use of gene therapy to treat Duchenne muscular dystrophy.

Journal: Expert opinion on biological therapy

Published: December 07, 2013

Showing 1-12 of 12

Last Updated: 09/26/2026